Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to -$87.9 million.

  • Mirum Pharmaceuticals' Net Income towards Common Stockholders rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Net Income towards Common Stockholders is -$87.9 million, which was up 46.18% from -$163.4 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Net Income towards Common Stockholders peaked at -$84.3 million during FY2021, and registered a low of -$163.4 million during FY2023.
  • In the last 3 years, Mirum Pharmaceuticals' Net Income towards Common Stockholders had a median value of -$135.7 million in 2022 and averaged -$129.0 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Net Income towards Common Stockholders crashed by 96.25% in 2020, and later surged by 46.18% in 2024.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Net Income towards Common Stockholders stood at -$103.4 million in 2020, then climbed by 18.50% to -$84.3 million in 2021, then crashed by 61.02% to -$135.7 million in 2022, then dropped by 20.45% to -$163.4 million in 2023, then skyrocketed by 46.18% to -$87.9 million in 2024.